Your browser doesn't support javascript.
loading
Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety.
Boudreau, Guy P; Grosberg, Brian M; McAllister, Peter J; Lipton, Richard B; Buse, Dawn C.
  • Boudreau GP; Clinique de la Migraine et Céphalées, Département de Neurologie, Centre Hospitalier de L'Université de Montréal, Hôpital Notre-Dame, Montreal, QC, Canada.
  • Grosberg BM; Montefiore Headache Center and the Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA.
  • McAllister PJ; New England Institute for Neurology and Headache, Stamford, and The Frank H Netter School of Medicine at Quinnipiac University, Hamden, CT, USA.
  • Lipton RB; Montefiore Headache Center and the Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Buse DC; Montefiore Headache Center and the Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA.
Int J Gen Med ; 8: 79-86, 2015.
Article en En | MEDLINE | ID: mdl-25733924
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Año: 2015 Tipo del documento: Article